Share Price and Basic Stock Data
Last Updated: October 18, 2025, 8:01 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
CNI Research Ltd operates within the Finance & Investments sector, with its stock currently priced at ₹10.00, yielding a market capitalization of ₹115 Cr. The company has demonstrated fluctuating revenue trends over recent quarters. Sales stood at ₹1.88 Cr in June 2022, peaking at ₹4.00 Cr in June 2024, before dropping significantly to ₹0.05 Cr in December 2024. The total sales for the trailing twelve months (TTM) reported for March 2024 was ₹10.42 Cr, illustrating a gradual recovery from the previous year’s ₹9.59 Cr. However, the quarterly sales results show volatility, with the latest quarter (September 2023) reporting sales of ₹2.56 Cr. The company’s operational efficiency is reflected in its Operating Profit Margin (OPM), which varied sharply, recorded at 10.71% in June 2025 but negative in several previous quarters, underscoring the inconsistent revenue stream and cost management practices. This inconsistency raises questions about the sustainability of revenue growth in a competitive financial landscape.
Profitability and Efficiency Metrics
CNI Research Ltd’s profitability metrics illustrate a challenging financial environment. The company reported a net profit of -₹3.94 Cr for the fiscal year ending March 2025, a decline from profits of ₹0.84 Cr in March 2024. The Earnings Per Share (EPS) figures reflect this downward trend, moving from ₹0.07 in March 2024 to -₹0.34 in March 2025. The Return on Equity (ROE) recorded at 25.3% and Return on Capital Employed (ROCE) also at 25.3%, both indicate a strong capacity to generate returns from equity and capital, though these figures are historical and do not account for the recent losses and operational challenges. The company’s cash conversion cycle remains at zero days, which suggests efficient cash management; however, the operating profit margins have fluctuated dramatically, with a low of -906.06% in September 2024, highlighting severe operational inefficiencies during certain periods. These inconsistencies in profitability metrics raise concerns about the company’s ability to maintain a stable profit trajectory moving forward.
Balance Sheet Strength and Financial Ratios
The balance sheet of CNI Research Ltd reflects a solid financial position with no reported borrowings, indicating a debt-free status, which is a significant strength in the current financial climate. As of March 2025, the company reported reserves of ₹4.77 Cr, a modest increase from the previous year. The Price to Book Value (P/BV) ratio stands at 3.04x, suggesting that the stock is trading at a premium relative to its book value, which is a common trend in the finance sector but may indicate overvaluation concerns. The current ratio is exceptionally high at 108.57, indicating strong liquidity and the ability to cover short-term liabilities easily. The interest coverage ratio is not applicable (N/A) due to the absence of debt, which further supports the company’s liquidity position. However, the significant swing in profit margins—from positive to negative—suggests that while the balance sheet appears robust, operational challenges could undermine financial stability if not addressed effectively.
Shareholding Pattern and Investor Confidence
The shareholding structure of CNI Research Ltd presents a stable yet cautious picture. Promoters hold 37.11% of the shares, a consistent figure across reporting periods, which reflects a strong commitment from the company’s founders. The public holds a significant 62.85%, while Foreign Institutional Investors (FIIs) have a minimal stake of 0.04%, indicating limited foreign interest in the company. The number of shareholders has increased from 10,786 in September 2022 to 19,713 by June 2025, suggesting a growing interest among retail investors, despite the recent financial struggles. This increase in shareholder count may reflect confidence in the company’s potential for recovery, despite the volatility in profits and operational challenges. However, the absence of substantial institutional investment raises concerns regarding broader market confidence. The reliance on public investment without significant institutional backing might pose risks if retail sentiment shifts rapidly.
Outlook, Risks, and Final Insight
If margins sustain their recovery trajectory and operational efficiencies are improved, CNI Research Ltd could stabilize its financial performance. However, the volatility in sales and profits poses significant risks. The company must address its operational inefficiencies, as evidenced by the fluctuating OPM and net profit figures. Furthermore, the reliance on public shareholders without robust institutional support may lead to instability in stock performance during adverse market conditions. The absence of debt is a considerable advantage, providing flexibility to navigate financial challenges. Nonetheless, if the company can leverage its strong balance sheet and improve its profitability metrics, it may foster renewed investor confidence. Continuous monitoring of operational strategies will be crucial for CNI Research Ltd to achieve sustainable growth in the increasingly competitive finance sector.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of CNI Research Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Modern Shares & Stockbrokers Ltd | 12.1 Cr. | 41.3 | 67.7/36.4 | 43.2 | 43.5 | 0.00 % | 3.32 % | 1.74 % | 10.0 |
| Monarch Networth Capital Ltd | 2,445 Cr. | 308 | 495/280 | 15.8 | 102 | 0.32 % | 33.3 % | 26.2 % | 10.0 |
| Monotype India Ltd | 37.3 Cr. | 0.53 | 2.42/0.46 | 3.62 | 0.02 | 0.00 % | 286 % | % | 1.00 |
| Multipurpose Trading & Agencies Ltd | 4.49 Cr. | 9.08 | 12.7/8.25 | 10.3 | 0.00 % | 3.68 % | 3.38 % | 10.0 | |
| Munoth Financial Services Ltd | 24.4 Cr. | 47.6 | 72.0/47.6 | 20.6 | 0.00 % | 2.41 % | 3.38 % | 10.0 | |
| Industry Average | 6,763.07 Cr | 1,429.69 | 132.51 | 3,769.18 | 0.31% | 21.70% | 14.20% | 7.28 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1.88 | 3.40 | 3.04 | 0.93 | 2.43 | 2.56 | 1.86 | 2.78 | 4.00 | 0.33 | 0.05 | 0.03 | 0.28 |
| Expenses | 1.89 | 3.29 | 2.95 | 0.97 | 2.47 | 2.50 | 1.78 | 2.82 | 3.96 | 3.32 | 0.95 | 0.14 | 0.25 |
| Operating Profit | -0.01 | 0.11 | 0.09 | -0.04 | -0.04 | 0.06 | 0.08 | -0.04 | 0.04 | -2.99 | -0.90 | -0.11 | 0.03 |
| OPM % | -0.53% | 3.24% | 2.96% | -4.30% | -1.65% | 2.34% | 4.30% | -1.44% | 1.00% | -906.06% | -1,800.00% | -366.67% | 10.71% |
| Other Income | 0.22 | 0.12 | 0.47 | -1.82 | 0.66 | 0.09 | -0.28 | 0.32 | 0.18 | -0.17 | -0.00 | 0.01 | -0.00 |
| Interest | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Depreciation | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Profit before tax | 0.21 | 0.23 | 0.56 | -1.86 | 0.62 | 0.15 | -0.20 | 0.28 | 0.22 | -3.16 | -0.90 | -0.10 | 0.03 |
| Tax % | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | 3.57% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% |
| Net Profit | 0.21 | 0.23 | 0.56 | -1.86 | 0.62 | 0.15 | -0.20 | 0.27 | 0.22 | -3.16 | -0.90 | -0.10 | 0.03 |
| EPS in Rs | 0.02 | 0.02 | 0.05 | -0.16 | 0.05 | 0.01 | -0.02 | 0.02 | 0.02 | -0.28 | -0.08 | -0.01 | 0.00 |
Last Updated: August 19, 2025, 9:00 pm
Below is a detailed analysis of the quarterly data for CNI Research Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 0.28 Cr.. The value appears strong and on an upward trend. It has increased from 0.03 Cr. (Mar 2025) to 0.28 Cr., marking an increase of 0.25 Cr..
- For Expenses, as of Jun 2025, the value is 0.25 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.14 Cr. (Mar 2025) to 0.25 Cr., marking an increase of 0.11 Cr..
- For Operating Profit, as of Jun 2025, the value is 0.03 Cr.. The value appears strong and on an upward trend. It has increased from -0.11 Cr. (Mar 2025) to 0.03 Cr., marking an increase of 0.14 Cr..
- For OPM %, as of Jun 2025, the value is 10.71%. The value appears strong and on an upward trend. It has increased from -366.67% (Mar 2025) to 10.71%, marking an increase of 377.38%.
- For Other Income, as of Jun 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 0.01 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 0.01 Cr..
- For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Depreciation, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 0.03 Cr.. The value appears strong and on an upward trend. It has increased from -0.10 Cr. (Mar 2025) to 0.03 Cr., marking an increase of 0.13 Cr..
- For Tax %, as of Jun 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00%.
- For Net Profit, as of Jun 2025, the value is 0.03 Cr.. The value appears strong and on an upward trend. It has increased from -0.10 Cr. (Mar 2025) to 0.03 Cr., marking an increase of 0.13 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.00. The value appears strong and on an upward trend. It has increased from -0.01 (Mar 2025) to 0.00, marking an increase of 0.01.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 3:37 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2.89 | 22.66 | 48.53 | 1.80 | 4.40 | 4.03 | 2.33 | -2.31 | 7.86 | 9.59 | 10.58 | 4.44 | 0.69 |
| Expenses | 3.19 | 23.93 | 48.25 | 2.18 | 4.51 | 4.53 | 2.58 | 1.30 | 6.14 | 10.45 | 9.73 | 8.38 | 4.66 |
| Operating Profit | -0.30 | -1.27 | 0.28 | -0.38 | -0.11 | -0.50 | -0.25 | -3.61 | 1.72 | -0.86 | 0.85 | -3.94 | -3.97 |
| OPM % | -10.38% | -5.60% | 0.58% | -21.11% | -2.50% | -12.41% | -10.73% | -10.17% | 21.88% | -8.97% | 8.03% | -88.74% | -575.36% |
| Other Income | 0.34 | 2.54 | -0.71 | 0.52 | 0.22 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.16 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.01 | 1.27 | -0.43 | 0.14 | 0.11 | -0.50 | -0.25 | -3.61 | 1.72 | -0.86 | 0.85 | -3.94 | -4.13 |
| Tax % | -1,600.00% | 20.47% | 0.00% | 14.29% | 18.18% | 0.00% | 0.00% | 0.00% | 1.16% | 0.00% | 1.18% | 0.00% | |
| Net Profit | 0.17 | 1.01 | -0.43 | 0.11 | 0.09 | -0.50 | -0.25 | -3.61 | 1.70 | -0.86 | 0.84 | -3.94 | -4.13 |
| EPS in Rs | 0.03 | 0.09 | -0.04 | 0.01 | 0.01 | -0.04 | -0.02 | -0.31 | 0.15 | -0.07 | 0.07 | -0.34 | -0.37 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 494.12% | -142.57% | 125.58% | -18.18% | -655.56% | 50.00% | -1344.00% | 147.09% | -150.59% | 197.67% | -569.05% |
| Change in YoY Net Profit Growth (%) | 0.00% | -636.69% | 268.16% | -143.76% | -637.37% | 705.56% | -1394.00% | 1491.09% | -297.68% | 348.26% | -766.72% |
CNI Research Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -15% |
| 5 Years: | 14% |
| 3 Years: | -17% |
| TTM: | -94% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -1039% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 50% |
| 3 Years: | 49% |
| 1 Year: | -1% |
| Return on Equity | |
|---|---|
| 10 Years: | -5% |
| 5 Years: | -11% |
| 3 Years: | -10% |
| Last Year: | -25% |
Last Updated: September 5, 2025, 3:01 pm
Balance Sheet
Last Updated: July 25, 2025, 1:33 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6.48 | 10.94 | 11.48 | 11.48 | 11.48 | 11.48 | 11.48 | 11.48 | 11.48 | 11.48 | 11.48 | 11.48 |
| Reserves | 5.61 | 11.35 | 11.19 | 6.48 | 4.72 | 0.24 | -5.93 | -3.67 | 0.97 | -2.02 | 3.43 | 4.77 |
| Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 0.15 | 0.58 | 0.28 | 0.04 | 0.03 | 0.01 | 0.10 | 0.07 | 0.05 | 0.02 | 0.02 | 0.05 |
| Total Liabilities | 12.24 | 22.87 | 22.95 | 18.00 | 16.23 | 11.73 | 5.65 | 7.88 | 12.50 | 9.48 | 14.93 | 16.30 |
| Fixed Assets | 0.02 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 10.55 | 17.33 | 22.40 | 17.53 | 14.47 | 11.42 | 5.32 | 7.51 | 11.09 | 8.65 | 12.44 | 12.81 |
| Other Assets | 1.67 | 5.53 | 0.54 | 0.46 | 1.76 | 0.31 | 0.33 | 0.37 | 1.41 | 0.83 | 2.49 | 3.49 |
| Total Assets | 12.24 | 22.87 | 22.95 | 18.00 | 16.23 | 11.73 | 5.65 | 7.88 | 12.50 | 9.48 | 14.93 | 16.30 |
Below is a detailed analysis of the balance sheet data for CNI Research Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 11.48 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 11.48 Cr..
- For Reserves, as of Mar 2025, the value is 4.77 Cr.. The value appears strong and on an upward trend. It has increased from 3.43 Cr. (Mar 2024) to 4.77 Cr., marking an increase of 1.34 Cr..
- For Borrowings, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 0.05 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.02 Cr. (Mar 2024) to 0.05 Cr., marking an increase of 0.03 Cr..
- For Total Liabilities, as of Mar 2025, the value is 16.30 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 14.93 Cr. (Mar 2024) to 16.30 Cr., marking an increase of 1.37 Cr..
- For Fixed Assets, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Investments, as of Mar 2025, the value is 12.81 Cr.. The value appears strong and on an upward trend. It has increased from 12.44 Cr. (Mar 2024) to 12.81 Cr., marking an increase of 0.37 Cr..
- For Other Assets, as of Mar 2025, the value is 3.49 Cr.. The value appears strong and on an upward trend. It has increased from 2.49 Cr. (Mar 2024) to 3.49 Cr., marking an increase of 1.00 Cr..
- For Total Assets, as of Mar 2025, the value is 16.30 Cr.. The value appears strong and on an upward trend. It has increased from 14.93 Cr. (Mar 2024) to 16.30 Cr., marking an increase of 1.37 Cr..
Notably, the Reserves (4.77 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -0.30 | -1.27 | 0.28 | -0.38 | -0.11 | -0.50 | -0.25 | -3.61 | 1.72 | -0.86 | 0.85 | -3.94 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 1.26 | 13.85 | 0.23 | 6.08 | 128.58 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Days | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 1.26 | 13.85 | 0.23 | 6.08 | 128.58 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Days | 190.71 | 8.54 | 0.08 | -2.03 | 126.09 | -0.91 | -15.67 | -11.06 | -1.86 | -0.38 | -0.34 | 268.00 |
| ROCE % | -0.83% | 1.11% | 1.96% | -0.54% | -0.64% | -3.58% | -2.90% | -54.04% | 16.98% | -7.85% | 6.98% | -25.29% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 0.07 | -0.07 | 0.15 | -0.31 | -0.02 |
| Diluted EPS (Rs.) | 0.07 | -0.07 | 0.15 | -0.31 | -0.02 |
| Cash EPS (Rs.) | 0.07 | -0.07 | 0.14 | -0.31 | -0.02 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 1.30 | 0.82 | 1.08 | 0.68 | 0.48 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 1.30 | 0.82 | 1.08 | 0.68 | 0.48 |
| Revenue From Operations / Share (Rs.) | 0.91 | 0.80 | 0.55 | 0.10 | 0.21 |
| PBDIT / Share (Rs.) | 0.07 | -0.07 | 0.14 | -0.31 | -0.02 |
| PBIT / Share (Rs.) | 0.07 | -0.07 | 0.14 | -0.31 | -0.02 |
| PBT / Share (Rs.) | 0.07 | -0.07 | 0.14 | -0.31 | -0.02 |
| Net Profit / Share (Rs.) | 0.07 | -0.07 | 0.14 | -0.31 | -0.02 |
| PBDIT Margin (%) | 8.12 | -9.26 | 26.98 | -304.76 | -9.97 |
| PBIT Margin (%) | 8.12 | -9.26 | 26.98 | -304.76 | -10.01 |
| PBT Margin (%) | 8.12 | -9.26 | 26.98 | -304.76 | -10.01 |
| Net Profit Margin (%) | 7.98 | -9.26 | 26.68 | -304.82 | -9.94 |
| Return on Networth / Equity (%) | 5.59 | -9.05 | 13.66 | -46.21 | -4.44 |
| Return on Capital Employeed (%) | 5.69 | -9.05 | 13.81 | -46.20 | -4.47 |
| Return On Assets (%) | 5.59 | -9.04 | 13.61 | -45.81 | -4.36 |
| Asset Turnover Ratio (%) | 0.85 | 0.84 | 0.62 | 0.17 | 0.28 |
| Current Ratio (X) | 108.57 | 47.93 | 30.97 | 5.13 | 3.13 |
| Quick Ratio (X) | 108.57 | 47.93 | 30.97 | 5.13 | 3.13 |
| Enterprise Value (Cr.) | 42.86 | 19.74 | 23.39 | 19.28 | 19.90 |
| EV / Net Operating Revenue (X) | 4.10 | 2.13 | 3.67 | 16.29 | 8.03 |
| EV / EBITDA (X) | 50.43 | -23.04 | 13.60 | -5.35 | -80.47 |
| MarketCap / Net Operating Revenue (X) | 4.34 | 2.22 | 3.89 | 16.58 | 8.15 |
| Price / BV (X) | 3.04 | 2.17 | 1.99 | 2.51 | 3.64 |
| Price / Net Operating Revenue (X) | 4.34 | 2.22 | 3.89 | 16.59 | 8.15 |
| EarningsYield | 0.01 | -0.04 | 0.06 | -0.18 | -0.01 |
After reviewing the key financial ratios for CNI Research Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 24, the value is 0.07. This value is below the healthy minimum of 5. It has increased from -0.07 (Mar 23) to 0.07, marking an increase of 0.14.
- For Diluted EPS (Rs.), as of Mar 24, the value is 0.07. This value is below the healthy minimum of 5. It has increased from -0.07 (Mar 23) to 0.07, marking an increase of 0.14.
- For Cash EPS (Rs.), as of Mar 24, the value is 0.07. This value is below the healthy minimum of 3. It has increased from -0.07 (Mar 23) to 0.07, marking an increase of 0.14.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 1.30. It has increased from 0.82 (Mar 23) to 1.30, marking an increase of 0.48.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 1.30. It has increased from 0.82 (Mar 23) to 1.30, marking an increase of 0.48.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 0.91. It has increased from 0.80 (Mar 23) to 0.91, marking an increase of 0.11.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 0.07. This value is below the healthy minimum of 2. It has increased from -0.07 (Mar 23) to 0.07, marking an increase of 0.14.
- For PBIT / Share (Rs.), as of Mar 24, the value is 0.07. This value is within the healthy range. It has increased from -0.07 (Mar 23) to 0.07, marking an increase of 0.14.
- For PBT / Share (Rs.), as of Mar 24, the value is 0.07. This value is within the healthy range. It has increased from -0.07 (Mar 23) to 0.07, marking an increase of 0.14.
- For Net Profit / Share (Rs.), as of Mar 24, the value is 0.07. This value is below the healthy minimum of 2. It has increased from -0.07 (Mar 23) to 0.07, marking an increase of 0.14.
- For PBDIT Margin (%), as of Mar 24, the value is 8.12. This value is below the healthy minimum of 10. It has increased from -9.26 (Mar 23) to 8.12, marking an increase of 17.38.
- For PBIT Margin (%), as of Mar 24, the value is 8.12. This value is below the healthy minimum of 10. It has increased from -9.26 (Mar 23) to 8.12, marking an increase of 17.38.
- For PBT Margin (%), as of Mar 24, the value is 8.12. This value is below the healthy minimum of 10. It has increased from -9.26 (Mar 23) to 8.12, marking an increase of 17.38.
- For Net Profit Margin (%), as of Mar 24, the value is 7.98. This value is within the healthy range. It has increased from -9.26 (Mar 23) to 7.98, marking an increase of 17.24.
- For Return on Networth / Equity (%), as of Mar 24, the value is 5.59. This value is below the healthy minimum of 15. It has increased from -9.05 (Mar 23) to 5.59, marking an increase of 14.64.
- For Return on Capital Employeed (%), as of Mar 24, the value is 5.69. This value is below the healthy minimum of 10. It has increased from -9.05 (Mar 23) to 5.69, marking an increase of 14.74.
- For Return On Assets (%), as of Mar 24, the value is 5.59. This value is within the healthy range. It has increased from -9.04 (Mar 23) to 5.59, marking an increase of 14.63.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 0.85. It has increased from 0.84 (Mar 23) to 0.85, marking an increase of 0.01.
- For Current Ratio (X), as of Mar 24, the value is 108.57. This value exceeds the healthy maximum of 3. It has increased from 47.93 (Mar 23) to 108.57, marking an increase of 60.64.
- For Quick Ratio (X), as of Mar 24, the value is 108.57. This value exceeds the healthy maximum of 2. It has increased from 47.93 (Mar 23) to 108.57, marking an increase of 60.64.
- For Enterprise Value (Cr.), as of Mar 24, the value is 42.86. It has increased from 19.74 (Mar 23) to 42.86, marking an increase of 23.12.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 4.10. This value exceeds the healthy maximum of 3. It has increased from 2.13 (Mar 23) to 4.10, marking an increase of 1.97.
- For EV / EBITDA (X), as of Mar 24, the value is 50.43. This value exceeds the healthy maximum of 15. It has increased from -23.04 (Mar 23) to 50.43, marking an increase of 73.47.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 4.34. This value exceeds the healthy maximum of 3. It has increased from 2.22 (Mar 23) to 4.34, marking an increase of 2.12.
- For Price / BV (X), as of Mar 24, the value is 3.04. This value exceeds the healthy maximum of 3. It has increased from 2.17 (Mar 23) to 3.04, marking an increase of 0.87.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 4.34. This value exceeds the healthy maximum of 3. It has increased from 2.22 (Mar 23) to 4.34, marking an increase of 2.12.
- For EarningsYield, as of Mar 24, the value is 0.01. This value is below the healthy minimum of 5. It has increased from -0.04 (Mar 23) to 0.01, marking an increase of 0.05.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in CNI Research Ltd:
- Net Profit Margin: 7.98%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 5.69% (Industry Average ROCE: 21.7%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 5.59% (Industry Average ROE: 14.2%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 108.57
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 132.51)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 7.98%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Finance & Investments | A/120, Gokul Arcade, Mumbai Maharashtra 400057 | chamatcar@chamatcar.com http://www.cniresearchltd.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Kishor P Ostwal | Managing Director |
| Mrs. Sangita K Ostwal | Non Exe.Non Ind.Director |
| Mr. Mayur Shantilal Doshi | Ind. Non-Executive Director |
| Mr. Arun Kumar S Jain | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of CNI Research Ltd?
CNI Research Ltd's intrinsic value (as of 18 October 2025) is 4.40 which is 57.28% lower the current market price of 10.30, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 118 Cr. market cap, FY2025-2026 high/low of 18.0/7.03, reserves of ₹4.77 Cr, and liabilities of 16.30 Cr.
What is the Market Cap of CNI Research Ltd?
The Market Cap of CNI Research Ltd is 118 Cr..
What is the current Stock Price of CNI Research Ltd as on 18 October 2025?
The current stock price of CNI Research Ltd as on 18 October 2025 is 10.3.
What is the High / Low of CNI Research Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of CNI Research Ltd stocks is 18.0/7.03.
What is the Stock P/E of CNI Research Ltd?
The Stock P/E of CNI Research Ltd is .
What is the Book Value of CNI Research Ltd?
The Book Value of CNI Research Ltd is 1.42.
What is the Dividend Yield of CNI Research Ltd?
The Dividend Yield of CNI Research Ltd is 0.00 %.
What is the ROCE of CNI Research Ltd?
The ROCE of CNI Research Ltd is 25.3 %.
What is the ROE of CNI Research Ltd?
The ROE of CNI Research Ltd is 25.3 %.
What is the Face Value of CNI Research Ltd?
The Face Value of CNI Research Ltd is 1.00.